Rushabh Medicals Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 15-11-2024
- Paid Up Capital ₹ 0.11 M
as on 15-11-2024
- Company Age 39 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 57.72%
(FY 2023)
- Profit 122.70%
(FY 2023)
- Ebitda 216.84%
(FY 2023)
- Net Worth 1.54%
(FY 2023)
- Total Assets 1.10%
(FY 2023)
About Rushabh Medicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Jayshree Doshi, Dinesh Doshi, Sharad Doshi, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110MH1985PTC037301
- Company No.
037301
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rushabh Medicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayshree Doshi  | Director | 01-Mar-2019 | Current |
| Dinesh Doshi | Director | 30-Aug-1985 | Current |
Sharad Doshi  | Director | 15-Sep-1987 | Current |
| Pranlal Doshi | Director | 30-Aug-1985 | Current |
Financial Performance and Corporate Structure Insights of Rushabh Medicals.
Rushabh Medicals Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 57.72% increase. The company also saw a substantial improvement in profitability, with a 122.7% increase in profit. The company's net worth moved up by a moderate rise of 1.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rushabh Medicals?
In 2023, Rushabh Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Blue Cross Hospitals Private LimitedActive 36 years 26 daysJayshree Doshi and Dinesh Doshi are mutual person
- Milan Cine Enterprises Private LimitedActive 38 years 7 months
Dinesh Doshi and Sharad Doshi are mutual person
- Cinema Owners And Exhibitors Association Of IndiaActive 78 years 26 days
Sharad Doshi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rushabh Medicals?
Unlock and access historical data on people associated with Rushabh Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rushabh Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rushabh Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
